How many studies have been conducted on Prodigiosin?

BiohacksAI has indexed 300 PubMed studies on Prodigiosin. 4% of studies involve human subjects.

What are the main research areas for Prodigiosin?

The primary research domains for Prodigiosin are 🔬 Oncology, 🔬 Inflammation, 🧠 Focus & Attention. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Prodigiosin

A toxic, bright red tripyrrole pigment from Serratia marcescens and others. It has antibacterial, anticoccidial, antimalarial, and antifungal activities, but is used mainly as a biochemical tool.

300+ PubMed studies analyzed · Evidence Score: 37

Research Domains

Prodigiosin has been studied across 12 research domains including 🔬 Oncology, 🔬 Inflammation, 🧠 Focus & Attention, 🛡️ Immunity, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 21% of studies addressing this area.

Loading evidence profile...

This evidence profile for Prodigiosin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.